Abivax Stock Drops After Short-Seller Calls Its Main Drug Toxic

Abivax shares fell after Scorpion Capital claimed its ulcerative colitis drug is toxic. The company rejected the report and reaffirmed its Phase 3 data.

Abivax Stock Drops After Short-Seller Calls Its Main Drug Toxic
Credit: Paul Yeung/Bloomberg
Already have an account? Sign in.